Mateon reported positive results for multiple COVID-19 drug candidates
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
On Mar. 25, 2020, CHF Solutions announced the use of its Aquadex therapy in the treatment of patients…
On Mar. 25, 2020, Merck announced it had donated 300,000 masks to New Jersey’s Office of Homeland Security…
On Mar. 25, 2020, the Perelman School of Medicine at the University of Pennsylvania announced it had established…
On Mar. 25, 2020, Mylan announced that it had waived its exclusive rights in the U.S. to distribute…
On Mar. 24, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the City of Miami…
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
On Mar. 24, 2020, a new international project aims to enroll 500 COVID-19 patients to search for genetic…
On Mar. 24, 2020, T2 Biosystems announced it had entered into a worldwide licensing agreement for a rapid…
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announceda research collaboration…
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the FDA for…
On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop…
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
On Mar. 23, 2020, Covetrus reported that the company saw strong demand in its prescription management and online…
On Mar. 23, 2020, Heat Biologics announced that it was collaborating with the University of Miami to develop…
On Mar. 23, 2020, LabCorpᆴ announced that it is exploring all options to prioritize COVID-19 testing for the…
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired…
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…